We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Adagrasib Nitroso Impurity 9
Adagrasib Nitroso Impurity 9
CAT No SRC-N0142142
CAS No 58246-54-1
Mol.F. C5H10N2O2
Mol.Wt. 130.1 g/mole
INV STATUS CUSTOM SYNTHESIS
Adagrasib Dinitroso Impurity 5
Adagrasib Dinitroso Impurity 5
CAT No SRC-N0142143
CAS No NA
Mol.F. C18H25N9O3
Mol.Wt. 415.5 g/mole
INV STATUS CUSTOM SYNTHESIS
Adagrasib Trinitroso Impurity 8
Adagrasib Trinitroso Impurity 8
CAT No SRC-N0142144
CAS No NA
Mol.F. C18H24N10O4
Mol.Wt. 444.5 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Adagrasib Impurity 4
N-Nitroso Adagrasib Impurity 4
CAT No SRC-N0142145
CAS No NA
Mol.F. C20H22ClN7O
Mol.Wt. 411.9 g/mole
INV STATUS CUSTOM SYNTHESIS
Adagrasib Nitroso Impurity 6
Adagrasib Nitroso Impurity 6
CAT No SRC-N0142146
CAS No NA
Mol.F. C28H30ClN9O3
Mol.Wt. 576.1 g/mole
INV STATUS CUSTOM SYNTHESIS
Adagrasib Nitroso Impurity 7
Adagrasib Nitroso Impurity 7
CAT No SRC-N0142147
CAS No NA
Mol.F. C28H31ClN8O2
Mol.Wt. 547.1 g/mole
INV STATUS CUSTOM SYNTHESIS
N6-methyl-N6-nitroso-Adenosine
N6-methyl-N6-nitroso-Adenosine
CAT No SRC-N0142148
CAS No 41286-73-1
Mol.F. C11H14N6O5
Mol.Wt. 310.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Dimethyl Amino Sugammadex
N-Nitroso Dimethyl Amino Sugammadex
CAT No SRC-N0142149
CAS No NA
Mol.F. C70H103N2O47S7
Mol.Wt. 1949.0 g/mole
INV STATUS CUSTOM SYNTHESIS
Sugammadex Nitroso Impurity 1
Sugammadex Nitroso Impurity 1
CAT No SRC-N0142150
CAS No NA
Mol.F. C70H110N2O47S7
Mol.Wt. 1956.0 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Adenosine Impurity A
N-Nitroso Adenosine Impurity A
CAT No SRC-N0142151
CAS No NA
Mol.F. C5H4N6O
Mol.Wt. 164.13 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.